Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer

Medical Oncology

Volumn 30, Issue 4, 2013, Pages

  Jiang, Tao ^a   Tang, Hua Mei ^a   Lu, Su ^a   Yan, Dong Wang ^a   Yang, Yin Xue ^b   Peng, Zhi Hai ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Immunohistochemistry; Prognosis; Tripartite motif containing 29

Indexed keywords

KI 67 ANTIGEN; PROTEIN TRIM29; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRIM29 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DOWN REGULATION; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR INVASION; UPREGULATION; VERY ELDERLY; YOUNG ADULT; COLORECTAL TUMOR; DISEASE COURSE; GENETICS; MORTALITY; PATHOLOGY; SURVIVAL; TUMOR CELL LINE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; HUMANS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 84891840808     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0715-4     Document Type: Article

References (29)

1. Jemal A, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
2. Gaedcke J, et al. The rectal cancer microRNAome-microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res. 2012;18(18):4919-30.
3. Siegel R, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212-36.
4. Zhang S, et al. Changes on the disease pattern of primary colorectal cancers in Southern China: a retrospective study of 20 years. Int J Colorectal Dis. 2009;24(8):943-9.
5. Schepeler T, et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 2008;68(15):6416-24.
6. Compton CC, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):979-94. (Pubitemid 30602039)
7. Nakamura Y, et al. Case of the multiple liver metastases from colon cancer obtained long-term disease-free survival with multimodality therapy. Gan To Kagaku Ryoho. 2012;39(12):2228-30.
8. Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6:479-507.
9. Yamaguchi H, Hsu JL, Hung MC. Regulation of ubiquitination-mediated protein degradation by survival kinases in cancer. Front Oncol. 2012;2:15.
10. Reymond A, et al. The tripartite motif family identifies cell compartments. EMBO J. 2001;20(9):2140-51. (Pubitemid 32410584)
11. Quaderi NA, et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet. 1997;17(3):285-91. (Pubitemid 27475990)
12. Wang L, et al. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell. 2009;15(3):207-19.
13. Kosaka Y, et al. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann Surg Oncol. 2007;14(9):2543-9. (Pubitemid 47389583)
14. Mutter GL, et al. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol. 2001;83(2):177-85. (Pubitemid 33033052)
15. Santin AD, et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer. 2004;112(1):14-25. (Pubitemid 39249487)
16. Dyrskjot L, et al. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res. 2004;64(11):4040-8. (Pubitemid 38697320)
17. Hawthorn L, et al. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung. Lung Cancer. 2006;53(2):129-42. (Pubitemid 43994230)
18. Li D, et al. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann Surg Oncol. 2009;16(12):3499-506.
19. Wang X, et al. Reduced expression of PER3 is associated with incidence and development of colon cancer. Ann Surg Oncol. 2012;19(9):3081-8.
20. Yan DW, et al. Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery. Br J Cancer. 2010;103(7):961-9.
21. Reddy BA, Etkin LD, Freemont PS. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci. 1992;17(9):344-5.
22. Borden KL. RING fingers and B-boxes: zinc-binding protein-protein interaction domains. Biochem Cell Biol. 1998;76(2-3):351-8. (Pubitemid 29102020)
23. Leonhardt EA, et al. Nucleotide sequence analysis of a candidate gene for ataxia-telangiectasia group D (ATDC). Genomics. 1994;19(1):130-6. (Pubitemid 24034376)
24. Sardiello M, et al. Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol Biol. 2008;8:225.
25. Brzoska PM, et al. The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc Natl Acad Sci U S A. 1995;92(17):7824-8.
26. Lawson JC, Blatch GL, Edkins AL. Cancer stem cells in breast cancer and metastasis. Breast Cancer Res Treat. 2009;118(2):241-54.
27. Yuan Z, et al. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol. 2010;30(12):3004-15.
28. Sho T, et al. TRIM29 negatively regulates p53 via inhibition of Tip60. Biochim Biophys Acta. 2011;1813(6):1245-53.
29. Shibata MA, et al. Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21. Cancer Gene Ther. 2001;8(1):23-35.